Search for: "Novartis Pharmaceuticals Inc" Results 281 - 300 of 394
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Dec 2011, 3:58 am by Lawrence B. Ebert
Bloomberg also reported: Pfizer has struck deals with companies including Catalyst Health Solutions Inc. and Coventry Health Care Inc. to prevent generic Lipitor from reaching some patients until the end of May 2012. [read post]
31 Dec 2010, 11:31 am by Bexis
Novartis Pharmaceuticals Corp., DA 10-0029  slip op., at 30 (Mont. [read post]
11 Jul 2007, 7:01 am
Another involved the short-lived product, Mylanta Night Time Strength Antacid (Novartis Consumer Health, Inc. v. [read post]
8 Feb 2011, 10:51 pm by Marie Louise
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes jury… [read post]
7 May 2009, 6:08 am
Novartis Pharmaceuticals Corp., 252 F.3d 986, 990 (8th Cir. 2001); Hans v. [read post]
22 Aug 2014, 9:22 am
Novartis Pharmaceutical Corp., 2013 WL 4648449 (M.D. [read post]
14 Jan 2021, 4:40 pm by anne
A $145 million settlement with EHR provider Practice Fusion, Inc., which was alleged to have accepted kickbacks from pharmaceutical companies including Purdue Pharma in exchange for implementing prompts in its EHR system that were designed to increase prescriptions of specific drugs. [read post]
9 Feb 2011, 8:02 pm by Laura Berndt
Novartis, a federal jury in New York ordered Novartis Pharmaceutical, Inc. to pay over $250 million in damages, including punitive damages, to current and former female Novartis employees who brought claims of  gender discrimination, including FRD. [read post]
28 Dec 2012, 1:57 pm by Bexis
McNeil Consumer & Specialty Pharmaceuticals, 672 F.3d 372 (5th Cir. 2012). [read post]
13 May 2010, 12:27 pm by Bexis
Novartis Pharmaceuticals Corp., 642 F. [read post]
25 Jan 2008, 1:00 am
: (Generic Pharmaceuticals & IP),Arava (Leflunomide) - Sanofi-Aventis loses bid to dismiss Louisiana Wholsesale Drug Co's antitrust claims accusing S-A of unlawfully blocking generic competition for Arava by filing a sham Citizen Petition with the USFDA: (IP Law360),Ciprofloxacin - CIPLA issued notice by National Pharmaceutical Pricing Authority for allegedly overpricing its antibiotic Ciprofloxacin (especially of note because CIPLA … [read post]